Vice President, Controller
Company websiteimux.com (Immunic Therapeutics, opens in new tab)
Base salary $290K – $350K
Employer-published annual base salary, USD. Advertised base range in Boston, MA
You apply on the employer's own site. Six Figure Work does not handle applications.
- LocationBoston, MA
- WorkplaceRemote
- Status at last checkSource accepting applications when checked
- Last checked (3 h ago) · observed since
About this job
Summary
We are seeking a VP Corporate Controller to lead our accounting function as Immunic transitions from clinical-stage development to commercial operations.
Reporting to the Executive VP of Finance, you will lead the accounting team and own the close, SEC reporting, internal controls and gross-to-net revenue accounting, partnering closely with Commercial, Market Access and Trade/Distribution.
You will join us as we build the finance infrastructure, controls, systems and team needed for the anticipated U.S. launch of our first product. The ideal candidate combines deep commercial-stage gross-to-net expertise with a hands-on, builder mindset and must be based on the east coast with direct biotech experience through Phase III.
Responsibilities
Design, implement and own gross-to-net (GTN) revenue accounting for our first commercial product, including reserves for chargebacks, rebates (commercial, Medicaid, Medicare Part D, 340B), distribution and data fees, co-pay assistance, returns and prompt-pay discounts.
Develop audit-ready GTN estimation methodologies, roll-forwards and true-up processes, applying ASC 606 variable consideration principles.
Partner with Market Access, Trade and Government Pricing to align contract terms, channel data and government pricing calculations (AMP, Best Price, ASP, Non-FAMP) with accounting.
Establish inventory accounting and costing (ASC 330), including pre-launch inventory capitalization, standard costing, CMO/3PL reconciliations and excess/obsolescence reserves.
Lead the monthly, quarterly and annual close, including clinical trial accruals, stock-based compensation, leases and other technical areas.
Prepare and review Forms 10-Q and 10-K, footnotes and supporting schedules in partnership with the CFO and SEC reporting resources.
Design and maintain a SOX-compliant internal control environment, scaling controls for new commercial processes (order-to-cash, GTN, inventory, procure-to-pay).
Serve as primary liaison with external auditors for quarterly reviews and the annual audit, and prepare technical accounting memos (with external consultants as needed) for new transactions and commercial arrangements.
Support the selection and implementation of a commercial-ready ERP and related systems, including GTN/revenue management and 3PL integrations.
Build, lead and develop a high-performing accounting team, manage outsourced accounting partners, and partner with FP&A on budgeting, forecasting and launch-related financial analysis.
Qualifications & Education
Bachelor’s degree in Accounting; CPA (active or inactive) required.
10+ years of progressive accounting experience, including Big 4 public accounting and public-company industry experience.
Direct, hands-on gross-to-net accounting experience at a commercial-stage pharmaceutical or biotechnology company, including establishing or managing GTN reserves and accruals.
Strong knowledge of U.S. GAAP (particularly ASC 606 and ASC 330), SEC reporting requirements and SOX 404 compliance, including designing internal controls.
Demonstrated ability to lead a close process and to manage and develop staff.
Excellent communication skills and the ability to partner cross-functionally with commercial and operational teams.
A builder mindset: hands-on, detail-oriented and strategic, with high integrity, sound judgment and strong ownership in a fast-paced, evolving environment.
Experience with Oracle NetSuite as an end user or administrator, ideally including a key role in a NetSuite implementation at a life sciences company preparing for commercialization, preferred.
Experience with Workiva for SEC reporting (10-Q/10-K, XBRL tagging) preferred.
Experience with a product launch, building commercial accounting processes from the ground up, preferred.
Familiarity with government pricing, the Medicaid Drug Rebate Program, 340B and specialty distribution models preferred.
Experience with GTN/contract management systems (e.g. Model N, IntegriChain, Revitas) preferred.
Immunic Therapeutics is an Equal Opportunity Employer. We are committed to fostering a diverse, inclusive, and equitable workplace where all individuals are valued and respected. Employment decisions are based on qualifications, merit, and business needs, without regard to race, color, religion, gender, sexual orientation, national origin, disability, veteran status, or any other protected status.
Please note, Immunic does not accept unsolicited resumes from external agencies or recruiters. Submission of a resume without a prior written agreement does not create any express or implied contract between Immunic and the agency. Immunic will not pay any fees related to unsolicited resumes.
Source: Immunic Therapeutics on Ashby · View original posting (opens in new tab)
How this pay compares
Base floor $290,000, above 98% of the 3,227 Finance & Accounting roles nationwide on this site. The employer's range is $60,000 wide, 21% of the floor. Observed open for 10 days so far (since Nov 10, 2026).
Pay in context
Among 3,227 Finance & Accounting roles nationwide listed on this site, the median base floor is $135,000 and the middle half runs from $115,000 to $169,140. This role's floor ($290,000) is above 98% of them.
Base floors of 3,227 Finance & Accounting roles nationwide
Table
| Floor band | Share | Postings |
|---|---|---|
| $100K to $125K | 37.6% | 1,213 |
| $125K to $150K | 23.8% | 768 |
| $150K to $175K | 16.6% | 537 |
| $175K to $200K | 9.7% | 312 |
| $200K to $225K | 5.7% | 184 |
| $225K to $250K | 2.9% | 94 |
| $250K to $275K | 1.9% | 61 |
| $275K and up | 1.8% | 58 |
How this is calculated
- Statistic
- Base floor distribution of the cohort
- Formula
- count of cohort postings in each $25K band of published base floor / postings in the cohort
- Denominator
- 3,227 open postings with this job family nationwide
- Sample size
- 3227
- Hidden when
- the cohort has fewer than 30 postings
- Calculation version
- jobpage-analysis-v1
- Data as of
- 2026-11-20
- Employer set
- Open jobs on this site that publish a base salary of $100,000 or more
Only jobs on this site count, and each one publishes a base salary of $100,000 or more, so this compares six-figure jobs with each other, not with the whole market. Computed Nov 20, 2026.
How Immunic Therapeutics pays
1 of Immunic Therapeutics's 13 live roles on this site list a higher base floor and 11 list a lower one. Across them the median floor is $220,000; the middle half runs from $190,000 to $235,000.
Base floors of Immunic Therapeutics's 13 live roles
Table
| Floor band | Share | Roles |
|---|---|---|
| $100K to $125K | 0.0% | 0 |
| $125K to $150K | 0.0% | 0 |
| $150K to $175K | 23.1% | 3 |
| $175K to $200K | 7.7% | 1 |
| $200K to $225K | 23.1% | 3 |
| $225K to $250K | 23.1% | 3 |
| $250K to $275K | 0.0% | 0 |
| $275K and up | 23.1% | 3 |
How this is calculated
- Statistic
- Employer base floor distribution
- Formula
- count of the employer's open roles in each $25K band of published base floor / its open roles
- Denominator
- 13 open public roles at this employer
- Sample size
- 13
- Hidden when
- this employer has fewer than 5 roles
- Calculation version
- jobpage-analysis-v1
- Data as of
- current
- Employer set
- Open jobs on this site that publish a base salary of $100,000 or more
Similar pay elsewhere
Other employers' Finance & Accounting roles nationwide with the nearest published base floor to $290,000, one per employer.
- Vice President, Tax Revolution Medicines · base floor $294,000
- Director, FP&A - HW Engineering & Supply Chain Waymo · base floor $285,000
- Senior Vice President, Head of Valuations HarbourVest Partners · base floor $285,000
- Vice President, Financial Planning & Analysis Western Digital · base floor $284,000
- Vice President, Corporate Controller Illumio · base floor $283,000
This listingVice President, Controller$290K – $350K
Vice President, Market Access$285K – $340K
Vice President, Pharmacovigilance$330K – $410K
Senior Director, IT Enterprise Applications$235K – $270K
Director, Scientific Communications$230K – $255K
Director, Health Economics & Outcomes Research$230K – $270K
Director, Applied AI Architect$220K – $250K
Chart as a table
| Role | Published base |
|---|---|
| Vice President, Controller (this listing) | $290K - $350K |
| Vice President, Market Access | $285K - $340K |
| Vice President, Pharmacovigilance | $330K - $410K |
| Senior Director, IT Enterprise Applications | $235K - $270K |
| Director, Scientific Communications | $230K - $255K |
| Director, Health Economics & Outcomes Research | $230K - $270K |
| Director, Applied AI Architect | $220K - $250K |
Observed changes
No changes to the pay or listing since we first observed this role on Nov 10, 2026 (10 days ago).
- First observed on the employer's board, already publishing a qualifying base salary
- Observed since
- Employer-stated posting date
- 2026-11-10
Where this pay comes from
Location as the employer wrote it: Remote - US • Boston, MA
USD 290,000 – 350,000 · 1 YEAR · Salary
- Method
- Structured pay field published by the employer
- Checked
- Rule set
- us-base-v2
The employer's job board publishes this pay as a dedicated data field. We read the field directly; no interpretation was needed.
What we verified
- The pay figures come from the employer's own listing, quoted exactly above.
- The pay is an annual base salary in US dollars with a minimum of at least $100,000.
- The role was publicly listed on the employer's job board when last checked.
We do not verify what the employer will actually offer, whether the employer is still recruiting for the role, or anything beyond what the employer published. Full methodology.
